Gender Male
LinkedIn View on LinkedIn
Dr. Gary Fanger has over 10 years of experience in the biotechnology industry developing novel therapeutics and establishing drug development alliances. Prior to joining Amplimmune, Dr. Fanger was Vice President of Business Development at MacroGenics where he directed partnering activities which included establishing MacroGenics' strategic
alliance with Eli Lilly & Company. Before MacroGenics, Dr. Fanger was responsible for a diverse array of corporate functions at Corixa Corporation including heading up business development activities, establishing and directing the therapeutic antibody development program, and managing numerous partnerships. Dr. Fanger has published over 45 articles, book chapters and reviews in high impact, peer-reviewed journals in the areas of monoclonal antibody development, cell biology and cancer research. He has also been awarded 28 patents. Dr. Fanger received his MBA from Seattle University, PhD in Molecular and Cellular Biology from Dartmouth Medical School and his BS in Chemistry from Denison University.
